Financials ZimVie Inc.

Equities

ZIMV

US98888T1079

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 21:00:00 13/05/2024 BST 5-day change 1st Jan Change
16.82 USD +1.02% Intraday chart for ZimVie Inc. +6.32% -5.24%

Valuation

Fiscal Period: December 2022 2023 2024 2025 2026
Capitalization 1 243.7 471 459 - -
Enterprise Value (EV) 1 686.3 471 459 459 459
P/E ratio - -1.19 x -6.57 x -6.18 x -6.52 x
Yield - - - - -
Capitalization / Revenue 0.27 x 0.54 x 1.01 x 1 x 0.99 x
EV / Revenue 0.27 x 0.54 x 1.01 x 1 x 0.99 x
EV / EBITDA 1.99 x 4.05 x 7.59 x 6.5 x 6.04 x
EV / FCF 29.8 x 15.4 x 6.9 x 6.55 x -
FCF Yield 3.35% 6.5% 14.5% 15.3% -
Price to Book 0.32 x - - - -
Nbr of stocks (in thousands) 26,088 26,536 27,289 - -
Reference price 2 9.340 17.75 16.82 16.82 16.82
Announcement Date 01/03/23 28/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net sales 1 1,015 913.9 866.7 453.8 458.5 465
EBITDA 1 131.6 122.5 116.4 60.5 70.6 76
EBIT 1 - 60.85 61.8 34.7 41.5 45.5
Operating Margin - 6.66% 7.13% 7.65% 9.05% 9.78%
Earnings before Tax (EBT) - - - - - -
Net income -95.3 - -393.3 - - -
Net margin -9.39% - -45.38% - - -
EPS 2 - - -14.87 -2.560 -2.720 -2.580
Free Cash Flow 1 - 8.171 30.64 66.5 70.1 -
FCF margin - 0.89% 3.54% 14.65% 15.29% -
FCF Conversion (EBITDA) - 6.67% 26.32% 109.92% 99.29% -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 31/03/22 01/03/23 28/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 235.6 214.6 229.1 225.4 224.9 202.9 213.5 118.2 115.2 105.3 115.1
EBITDA 1 33.85 29.38 28.05 32.08 29.72 25.84 - 12.45 15.8 14.3 18
EBIT 1 19.18 14.05 11.49 18.92 14.25 12.24 - 7.593 8.8 7.3 11
Operating Margin 8.14% 6.55% 5.01% 8.39% 6.34% 6.03% - 6.42% 7.64% 6.93% 9.56%
Earnings before Tax (EBT) - - - - - - - - - - -
Net income - - - - - - - - - - -
Net margin - - - - - - - - - - -
EPS 2 -0.9800 0.0300 - - - - - -0.2900 -0.7400 -0.7600 -0.6400
Dividend per Share - - - - - - - - - - -
Announcement Date 05/05/22 09/11/22 01/03/23 03/05/23 02/08/23 01/11/23 28/02/24 08/05/24 - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net Debt - 443 - - - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - 3.612 x - - - -
Free Cash Flow 1 - 8.17 30.6 66.5 70.1 -
ROE (net income / shareholders' equity) - 4.33% - - - -
ROA (Net income/ Total Assets) - 2.76% - - - -
Assets - - - - - -
Book Value Per Share - 28.90 - - - -
Cash Flow per Share - - - - - -
Capex 1 - 16.5 6.51 10.2 11.2 -
Capex / Sales - 1.8% 0.75% 2.25% 2.44% -
Announcement Date 31/03/22 01/03/23 28/02/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
16.82 USD
Average target price
16 USD
Spread / Average Target
-4.88%
Consensus
  1. Stock Market
  2. Equities
  3. ZIMV Stock
  4. Financials ZimVie Inc.